1. Home
  2. AVXL vs SSTK Comparison

AVXL vs SSTK Comparison

Compare AVXL & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • SSTK
  • Stock Information
  • Founded
  • AVXL 2004
  • SSTK 2003
  • Country
  • AVXL United States
  • SSTK United States
  • Employees
  • AVXL N/A
  • SSTK N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • SSTK EDP Services
  • Sector
  • AVXL Health Care
  • SSTK Technology
  • Exchange
  • AVXL Nasdaq
  • SSTK Nasdaq
  • Market Cap
  • AVXL 794.0M
  • SSTK 644.4M
  • IPO Year
  • AVXL N/A
  • SSTK 2012
  • Fundamental
  • Price
  • AVXL $10.57
  • SSTK $19.91
  • Analyst Decision
  • AVXL Strong Buy
  • SSTK Buy
  • Analyst Count
  • AVXL 2
  • SSTK 4
  • Target Price
  • AVXL $44.00
  • SSTK $43.67
  • AVG Volume (30 Days)
  • AVXL 890.2K
  • SSTK 287.0K
  • Earning Date
  • AVXL 08-05-2025
  • SSTK 08-05-2025
  • Dividend Yield
  • AVXL N/A
  • SSTK 6.62%
  • EPS Growth
  • AVXL N/A
  • SSTK N/A
  • EPS
  • AVXL N/A
  • SSTK 1.09
  • Revenue
  • AVXL N/A
  • SSTK $963,567,000.00
  • Revenue This Year
  • AVXL N/A
  • SSTK $11.31
  • Revenue Next Year
  • AVXL N/A
  • SSTK $2.40
  • P/E Ratio
  • AVXL N/A
  • SSTK $18.37
  • Revenue Growth
  • AVXL N/A
  • SSTK 10.30
  • 52 Week Low
  • AVXL $4.00
  • SSTK $14.35
  • 52 Week High
  • AVXL $14.44
  • SSTK $46.10
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 74.00
  • SSTK 61.05
  • Support Level
  • AVXL $9.08
  • SSTK $18.26
  • Resistance Level
  • AVXL $9.78
  • SSTK $20.53
  • Average True Range (ATR)
  • AVXL 0.51
  • SSTK 0.75
  • MACD
  • AVXL 0.14
  • SSTK 0.15
  • Stochastic Oscillator
  • AVXL 93.36
  • SSTK 79.33

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

Share on Social Networks: